Olafsson, Jonatan
Lai, Xiaoran
Landsend, Erlend Christoffer Sommer
Olafsson, Snorri
Parissi, Eric
Utheim, Øygunn A.
Raeder, Sten
Badian, Reza A.
Lagali, Neil
Dartt, Darlene A.
Utheim, Tor P.
Funding for this research was provided by:
Faculty of Medicine, University of Oslo
Medilens Nordic AB
Thea Laboratories
Bausch & Lomb Nordic AB
Article History
Received: 31 August 2021
Accepted: 3 November 2021
First Online: 17 November 2021
Competing interests
: Snorri Olafsson is on the speaker bureau for Takeda Pharmaceuticals. Tor Paaske Utheim is co-founder and co-owner of The Norwegian dry eye clinic, which delivers talks for and/or receives financial support from the following: ABIGO, Alcon, Allergan, AMWO, Bausch&Lomb, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire and Thea Laboratoires. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire. Utheim is the Norwegian Global Ambassador for Tear Film and Ocular Surface Society (TFOS) and a board member of the International Ocular Surface Society. Sten Raeder has financial disclosers for Abigo, Alcon, AMWO, Bausch & Lomb, Medilens, Medistim, Novartis, Santen, Théa. In addition, he has co-founded the Norwegian Dry Eye Clinic. Darlene Dartt is a consultant for Coopervision. Jonatan Olafsson, Xiaoran Lai, Erlend Christoffer Sommer Landsend, Eric Parissi, Reza A. Badian, and Neil Lagali have no competing interests.